Normalized Subendocardial Myocardial Attenuation on Coronary Computed Tomography Angiography Predicts Postoperative Adverse Cardiovascular Events: Coronary CTA VISION Substudy.


Journal

Circulation. Cardiovascular imaging
ISSN: 1942-0080
Titre abrégé: Circ Cardiovasc Imaging
Pays: United States
ID NLM: 101479935

Informations de publication

Date de publication:
01 2022
Historique:
entrez: 18 1 2022
pubmed: 19 1 2022
medline: 26 2 2022
Statut: ppublish

Résumé

Abnormalities in computed tomography myocardial perfusion has been associated with coronary artery disease and major adverse cardiovascular events (MACE). We sought to investigate if subendocardial attenuation using coronary computed tomography angiography predicts MACE 30 days postelective noncardiac surgery. Using a 17-segment model, coronary computed tomography angiography images were analyzed for subendocardial and transmural attenuation and the corresponding blood pool. The segment with the lowest subendocardial attenuation and transmural attenuation were normalized to the segment with the highest subendocardial and transmural attenuation, respectively (SUB Of a total of 995 coronary CTA VISION (Coronary Computed Tomographic Angiography and Vascular Events in Noncardiac Surgery Patients Cohort Evaluation Study) patients, 735 had available images and complete data for these analyses. Among these patients, 60 had MACE. Based on Revised Cardiovascular Risk Index, 257, 302, 138, and 38 patients had scores of 0, 1, 2, and ≥3, respectively. On coronary computed tomography angiography, 75 patients had normal coronary arteries, 297 patients had nonobstructive coronary artery disease, 264 patients had obstructive disease, and 99 patients had extensive obstructive coronary artery disease. SUB Our study demonstrates that SUB

Sections du résumé

BACKGROUND
Abnormalities in computed tomography myocardial perfusion has been associated with coronary artery disease and major adverse cardiovascular events (MACE). We sought to investigate if subendocardial attenuation using coronary computed tomography angiography predicts MACE 30 days postelective noncardiac surgery.
METHODS
Using a 17-segment model, coronary computed tomography angiography images were analyzed for subendocardial and transmural attenuation and the corresponding blood pool. The segment with the lowest subendocardial attenuation and transmural attenuation were normalized to the segment with the highest subendocardial and transmural attenuation, respectively (SUB
RESULTS
Of a total of 995 coronary CTA VISION (Coronary Computed Tomographic Angiography and Vascular Events in Noncardiac Surgery Patients Cohort Evaluation Study) patients, 735 had available images and complete data for these analyses. Among these patients, 60 had MACE. Based on Revised Cardiovascular Risk Index, 257, 302, 138, and 38 patients had scores of 0, 1, 2, and ≥3, respectively. On coronary computed tomography angiography, 75 patients had normal coronary arteries, 297 patients had nonobstructive coronary artery disease, 264 patients had obstructive disease, and 99 patients had extensive obstructive coronary artery disease. SUB
CONCLUSIONS
Our study demonstrates that SUB

Identifiants

pubmed: 35041449
doi: 10.1161/CIRCIMAGING.121.012654
doi:

Banques de données

ClinicalTrials.gov
['NCT01635309']

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e012654

Subventions

Organisme : CIHR
Pays : Canada

Auteurs

Jeroen Walpot (J)

Division of Cardiology (J.W., S.M., P.J., M.S., O.C., L.G., A.S., I.R., K.G., K.J., A.M.C., B.J.W.C.), University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Samia Massalha (S)

Division of Cardiology (J.W., S.M., P.J., M.S., O.C., L.G., A.S., I.R., K.G., K.J., A.M.C., B.J.W.C.), University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Pranisha Jayasinghe (P)

Division of Cardiology (J.W., S.M., P.J., M.S., O.C., L.G., A.S., I.R., K.G., K.J., A.M.C., B.J.W.C.), University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Madiha Sadaf (M)

Division of Cardiology (J.W., S.M., P.J., M.S., O.C., L.G., A.S., I.R., K.G., K.J., A.M.C., B.J.W.C.), University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Owen Clarkin (O)

Division of Cardiology (J.W., S.M., P.J., M.S., O.C., L.G., A.S., I.R., K.G., K.J., A.M.C., B.J.W.C.), University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Laura Godkin (L)

Division of Cardiology (J.W., S.M., P.J., M.S., O.C., L.G., A.S., I.R., K.G., K.J., A.M.C., B.J.W.C.), University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Ashwin Sharma (A)

Division of Cardiology (J.W., S.M., P.J., M.S., O.C., L.G., A.S., I.R., K.G., K.J., A.M.C., B.J.W.C.), University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Indeevari Ratnayake (I)

Division of Cardiology (J.W., S.M., P.J., M.S., O.C., L.G., A.S., I.R., K.G., K.J., A.M.C., B.J.W.C.), University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Kara Godkin (K)

Division of Cardiology (J.W., S.M., P.J., M.S., O.C., L.G., A.S., I.R., K.G., K.J., A.M.C., B.J.W.C.), University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Kateleen Jia (K)

Division of Cardiology (J.W., S.M., P.J., M.S., O.C., L.G., A.S., I.R., K.G., K.J., A.M.C., B.J.W.C.), University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Alomgir Hossain (A)

Cardiovascular Research Methods Centre (A.H.), University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Andrew M Crean (AM)

Division of Cardiology (J.W., S.M., P.J., M.S., O.C., L.G., A.S., I.R., K.G., K.J., A.M.C., B.J.W.C.), University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Department of Radiology, University of Ottawa, Ontario, Canada (A.M.C., B.J.W.C.).

Matthew Chan (M)

Department of Anesthesia and Intensive Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region (M.C.).

Craig Butler (C)

Department of Medicine (Cardiology), Alberta Heart Institute and University of Alberta, Edmonton, Alberta, Canada (C.B.).

Vikas Tandon (V)

Population Health Research Institute and Department of Medicine, David Braley Cardiac, Vascular, and Stroke Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada (V.T., P.J.D., T.S.).

Peter Nagele (P)

Department of Anesthesiology (P.N.), Washington University School of Medicine, St. Louis, MO.
Department of Anesthesia and Critical Care, University of Chicago, IL (P.N.).

Pamela K Woodard (PK)

Mallinckrodt Institute of Radiology (P.K.W.), Washington University School of Medicine, St. Louis, MO.

Marko Mrkobrada (M)

Department of Medicine, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada (M.M.).

Wojciech Szczeklik (W)

Department of Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Krakow, Poland (W.S.).

Yang Faridah Abdul Aziz (YFA)

Department of Biomedical Imaging, University Malaya Research Imaging Centre, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (Y.F.A.A.).

Bruce Biccard (B)

Department of Anaesthesia and Perioperative Medicine, Groote Schuur Hospital, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa (B.B.).

P J Devereaux (PJ)

Population Health Research Institute and Department of Medicine, David Braley Cardiac, Vascular, and Stroke Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada (V.T., P.J.D., T.S.).

Tej Sheth (T)

Population Health Research Institute and Department of Medicine, David Braley Cardiac, Vascular, and Stroke Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada (V.T., P.J.D., T.S.).

Benjamin J W Chow (BJW)

Division of Cardiology (J.W., S.M., P.J., M.S., O.C., L.G., A.S., I.R., K.G., K.J., A.M.C., B.J.W.C.), University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Department of Radiology, University of Ottawa, Ontario, Canada (A.M.C., B.J.W.C.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH